Drug intelligence / Profile preview

Jena DM + metformin

Development stage
Unknown
Modality
Small Molecules
Administration
Oral
01

Overview

Jena DM + metformin is a combination therapy used in the management of type 2 diabetes mellitus. Jena DM is a licensed herbal formulation in Uganda, primarily containing extracts of Cymbopogon citratus (lemongrass), and is used as a complementary therapy alongside standard oral hypoglycemic agents such as metformin. Metformin is a biguanide antihyperglycemic agent that decreases hepatic glucose production, increases insulin sensitivity, and reduces appetite via GDF15 secretion. The combination aims to improve glycemic control and may have additive effects on weight reduction; however, clinical studies indicate that while Jena DM does not significantly reduce HbA1c when added to metformin, it can lead to modest weight loss but also increases the risk of adverse events such as dizziness and epigastric pain[1][6]. The mechanism of action for Jena DM likely involves phytochemicals with potential hypoglycemic activity from Cymbopogon citratus, though precise molecular targets are not fully characterized.

Other names
Jena DM + metformin
02

Targets

ND1 (Mitochondrial electron transport chain complex I)

Beyond the preview

Go deeper on Jena DM + metformin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jena DM + metformin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call